Neuropsychopharmacology (journal)
![]() | |
Discipline | Neuropsychopharmacology |
---|---|
Language | English |
Edited by | Tony P. George, Lisa M. Monteggia |
Publication details | |
History | 1987-present |
Publisher | Nature Portfolio |
Frequency | Monthly |
Open access | Hybrid; delayed, after 6 months |
Impact factor | 7.6 (2022) |
Standard abbreviations ISO 4 (alt) · Bluebook (alt1 · alt2) NLM (alt) · MathSciNet (alt ![]() | |
ISO 4 | Neuropsychopharmacology |
Indexing CODEN (alt · alt2) · JSTOR (alt) · LCCN (alt) MIAR · NLM (alt) · Scopus | |
CODEN | NEROEW |
ISSN | 0893-133X (print) 1740-634X (web) |
OCLC no. | 815994337 |
Links | |
|
Neuropsychopharmacology is a monthly peer-reviewed scientific journal published by Nature Portfolio. It was established in 1987 and is an official publication of the American College of Neuropsychopharmacology. The journal covers all aspects of neuropsychopharmacology, including clinical and basic science research into the brain and behavior, the properties of agents acting within the central nervous system, and drug targeting and development. In addition to primary articles and reviews, the journal publishes Brainpod, a podcast highlighting content published in the journal and featuring interviews with the authorship team.[1]
Editors-in-chief
Over the years, there have been ten editors-in-chief ("principal editors"), including J. Christian Gillin (1987-1993), Ronald D. Ciaranello (1994), Herbert Y. Meltzer (1994-1998), Hans C. Fibiger (1995-1998), Robert H. Lenox (1999-2001), Charles B. Nemeroff (2002-2006), and James H. Meador-Woodruff (2007-2012) and William A. Carlezon, Jr. (2013-2022).[2] Since 2023, Tony P. George (University of Toronto) and Lisa M. Monteggia (Vanderbilt University) have been co-editors.
Abstracting and indexing
The journal is abstracted and indexed in:
- Biological Abstracts[3]
- BIOSIS Previews[3]
- CAB Abstracts[4]
- Chemical Abstracts Service[5]
- Current Contents/Life Sciences[3]
- EBSCO databases[6]
- Embase[7]
- Index Medicus/MEDLINE/PubMed[8]
- PASCAL[6]
- PsycINFO[9]
- Science Citation Index Expanded[3]
- Scopus[10]
According to the Journal Citation Reports, the journal has a 2022 impact factor of 7.6.[11]
References
- ^ "Podcasts | Neuropsychopharmacology". www.nature.com. Retrieved 2024-03-21.
- ^ "About the Editors".
- ^ a b c d "Web of Science Master Journal List". Intellectual Property & Science. Clarivate. Retrieved 2022-06-04.
- ^ "Serials cited". CAB Abstracts. CABI. Retrieved 2022-06-04.
- ^ "CAS Source Index". Chemical Abstracts Service. American Chemical Society. Retrieved 2022-06-04.
- ^ a b "Neuropsychopharmacology". MIAR: Information Matrix for the Analysis of Journals. University of Barcelona. Retrieved 2022-06-04.
- ^ "Embase Coverage". Embase. Elsevier. Retrieved 2022-06-04.
- ^ "Neuropsychopharmacology". NLM Catalog. National Center for Biotechnology Information. Retrieved 2022-06-04.
- ^ "PsycINFO Journal Coverage". American Psychological Association. Retrieved 2022-06-04.
- ^ "Source details: Neuropsychopharmacology". Scopus Preview. Elsevier. Retrieved 2022-06-04.
- ^ "Neuropsychopharmacology". 2022 Journal Citation Reports (Science ed.). Clarivate. 2023 – via Web of Science.
External links
- Official website
- v
- t
- e
DIE ZEIT Verlagsgruppe |
|
---|---|
Digital & Services |
![](http://upload.wikimedia.org/wikipedia/commons/thumb/6/64/Logo_Holtzbrinck_Publ_Group.png/120px-Logo_Holtzbrinck_Publ_Group.png)
United States |
| ||||||
---|---|---|---|---|---|---|---|
United Kingdom |
| ||||||
Germany |
|
- Apress
- BioMed Central
- Birkhäuser
- Macmillan Education
- Nature Research
- Journals
- Palgrave Macmillan
- Journals
- Scientific American
- Springer
- Journals
- Springer Gabler
- Springer Medizin
- Springer Vieweg